NIH SBIR Funding Opportunities for Healthcare Chatbots, Conversational AI, AI Safety, Digital Therapeutics, Clinical Decision Support, Responsible AI, and Behavioral Health Technology Innovation

NIH SBIR Funding Opportunities for Healthcare Chatbots, Conversational AI, AI Safety, Digital Therapeutics, Clinical Decision Support, Responsible AI, and Behavioral Health Technology Innovation is sponsored by National Institutes of Health (NIH).

This program encourages innovative research proposals focused on understanding the benefits, harms, safety, and long-term impacts of conversational chatbot technologies in healthcare and health-related settings.

It is particularly interested in projects that move beyond proof-of-concept to investigate causal mechanisms, unintended consequences, misinformation risks, automation bias, dependency, delayed professional care, and safe deployment practices.

NIH Highlighted Topic: Healthcare Chatbots, Conversational AI & Responsible AI Research SBIR Funding Opportunity — BW&CO NIH Highlighted Topic: Research on Chatbots and their Usage Below is a brief summary. Please check the full solicitation before applying (link in resources section).

The National Institutes of Health (NIH) is encouraging innovative research proposals focused on understanding the benefits, harms, safety, and long-term impacts of conversational chatbot technologies in healthcare and health-related settings.

This highlighted topic supports multidisciplinary projects designed to rigorously evaluate how chatbot design, personalization, safeguards, and patterns of use influence health outcomes, clinical decision-making, autonomy, behavior, and trust across diverse populations and real-world contexts.

NIH recognizes that chatbots are increasingly used for symptom interpretation, chronic disease management, mental health support, caregiving, treatment decision-making, health information access, and social interaction — often without professional oversight.

The initiative is particularly interested in projects that move beyond proof-of-concept to investigate causal mechanisms, unintended consequences, misinformation risks, automation bias, dependency, delayed professional care, and safe deployment practices.

Companies developing healthcare chatbots, AI safety platforms, conversational AI systems, digital therapeutics, clinical decision support tools, chatbot evaluation frameworks, governance systems, behavioral analytics platforms, or AI monitoring technologies may be strong candidates for funding.

Areas of interest include chatbot safety benchmarking, longitudinal user behavior analysis, AI transparency, guardrails and escalation systems, misinformation mitigation, mental health and substance use chatbot interventions, cancer care support tools, chatbot-human clinical integration, explainable AI systems, conversational AI for older adults and caregivers, and responsible AI frameworks aligned with healthcare interoperability standards such as FHIR and SMART on FHIR.

Funding is available through the NIH SBIR/STTR Program, which currently provides up to approximately $323,090 for Phase I projects and up to $2,153,927 for Phase II projects, with opportunities for additional commercialization and follow-on funding depending on project scope and translational impact.

This highlighted topic is supported by multiple NIH Institutes and Offices including NIA, NCCIH, NCI, NIDA, NIDCR, NIMH, NLM, OBSSR, and ODSS, all of which are seeking transformative innovations that improve safe, ethical, evidence-based deployment of conversational AI and chatbot technologies in healthcare and public health environments. How much funding would I receive?

Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.

What could I use the funding for? Funding may support the research, development, validation, implementation, and commercialization of healthcare chatbot technologies, AI safety systems, conversational AI governance platforms, behavioral analytics tools, and clinical decision support solutions.

Eligible activities may include: Healthcare chatbot and conversational AI platform development AI safety monitoring, guardrails, and escalation systems Chatbot benchmarking, validation, and misinformation detection frameworks Clinical decision support and symptom interpretation technologies Mental health, substance use disorder, and behavioral health chatbot systems Cancer care support, patient education, and survivorship chatbot platforms Longitudinal user engagement and dependency analytics systems Explainable AI, transparency, and responsible AI governance tools Conversational AI systems for older adults, caregivers, and vulnerable populations AI-enabled risk stratification and safety monitoring technologies Digital therapeutics and chatbot-assisted intervention platforms FHIR, SMART on FHIR, and healthcare interoperability integration systems Behavioral and social science analytics related to chatbot usage patterns Human-centered AI design and co-development frameworks Clinical workflow integration and provider oversight systems Privacy-preserving conversational AI and secure data-sharing infrastructure Prototype development, translational studies, and real-world validation research Commercialization planning, regulatory preparation, and implementation scaling activities Funding may also support personnel, software engineering, cloud infrastructure, AI model development, cybersecurity systems, user research, behavioral analytics, implementation science, interoperability integration, stakeholder engagement, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable healthcare AI or conversational technology solution aligned with NIH priorities.

Are there any additional benefits I would receive? Beyond the formal funding award, awardees gain several strategic advantages: Government Validation and Credibility: Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.

Enhanced Visibility and Market Recognition: Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities. Access to the Federal Innovation Ecosystem: Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.

Stronger Commercial and Exit Potential: By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment. What is the timeline to apply and when would I receive funding? Applications are accepted each year on January 5th, April 5th, and September 5th.

Funding is received approximately 9 months after submission. Where does this funding come from? Funding comes from the U.S. Department of Health and Human Services , with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.

2% for SBIR, 0. 45% for STTR) to support small business innovation. Who is eligible to apply?

Applicants must be U.S. small business concerns (SBCs) that: Are organized for profit with a U.S. place of business. Have ≤ 500 employees including affiliates. Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.

What companies and projects are likely to win? Projects that demonstrate: A clear unmet medical or public-health need , Strong scientific rationale and feasibility , High commercialization potential , supported by a realistic market and regulatory strategy, and Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).

Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption. Are there any restrictions I should know about? Companies must complete multiple federal registrations ( SAM.

gov , Grants. gov , eRA Commons, SBA Company Registry) before applying. Foreign entities are not eligible .

Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation. How long will it take me to prepare an application?

For a first-time applicant , preparing a competitive submission will likely take 120–200 hours in total.

Our team specializes in complex federal R&D proposals and can: Triple your likelihood of success through proven strategy and insider-aligned proposal development Reduce your time spent on the proposal by 50–80% , letting your team focus on technology and operations Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth. Review solicitation here.

Biotech Medtech Healthtech NIH Highlighted Topic: Breaking Barriers: Integrating Immunology and Neuroscience to Transform AD/ADRD Research and Bring a Better Understanding of the Aging Brain NIH Highlighted Topic: Strengthening Biomedical Research, Promoting Trust, and Improving Health through Bioethics Research